Test that could identify signs of Alzheimer’s disease 20 years earlier greenlit for trials
The ability to test for signs of Alzheimer’s disease decades earlier could be a step closer with a…
UK lags behind global countries in managing chronic health: Zurich
The provider has published its latest report, The Value of Chronic Care, which analysed all 38 countries of…
Experimental Alzheimer’s Drug Candidate Slowed Disease Progression In Mice And Appeared To Slow Aging
(Credit: © Robert Kneschke | Dreamstime.com) New Alzheimer’s Drug Candidate Targets a Different Mechanism Than Existing Treatments In…
Roche Receives CE Mark for Alzheimer’s Disease Blood Test
Roche received the CE mark for its Elecsys pTau217 blood test, an assay designed to detect Alzheimer’s disease…
Local clinicians attend Alzheimer’s summit in Geneva | Life
Local clinicians attend Alzheimer’s summit By Ross Freake Local Journalism Initiative The first gold-standard brain and dementia care…
Local clinicians attend Alzheimer’s summit in Geneva | Life
Local clinicians attend Alzheimer’s summit By Ross Freake Local Journalism Initiative The first gold-standard brain and dementia care…
Roche Receives CE Mark for Blood-Based Immunoassay Test to Detect Alzheimer’s Genetic Risk Factor ApoE4
Roche has received CE Mark approval for its Elecsys Apolipoprotein E4 (ApoE4) biomarker test, an in-vitro diagnostic (IVD)…
Roche secures CE mark for blood test to identify ApoE4 carriers
Roche Holding AG received CE Mark approval for its Elecsys Apolipoprotein E4 (ApoE4) biomarker test, an in vitro…
FDA clears Roche, Lilly Alzheimer’s blood test
A blood test developed by Roche and Eli Lilly that could help diagnose patients with Alzheimer’s disease more…